2019 NURS-6630N Nursing Diagnosis Week 11 Final Exam With Answers (76 Solved Questions)

Name: 2019 NURS-6630N Nursing Diagnosis Week 11 Final Exam With Answers (76 Solved Questions)
Brand: Walden University
Price: 3 USD
Availability: InStock
Author: Miles Rogers

With 2019 NURS-6630N Nursing Diagnosis Week 11 Final Exam With Answers, you get access to a valuable archive of past exam papers to enhance your study sessions.

Miles Rogers

Contributor

4.0

13 days ago

Preview (6 of 19)

User Cynthia Rochelle Archie
Course NURS-6630N
Test Week 11 Final Exam
Started 2/6/19 9:14 AM
Submitted 2/6/19 11:08 AM
Due Date 2/11/19 1:59 AM
Status Completed
Attempt Score 73 out of 75 points
Time Elapsed 1 hour, 54 minutes out of
2 hours
Results
Displayed
Submitted Answers
 Question 1
1 out of 1 points
Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP
prescribe for Mrs. Rosen to improve this condition?
Selected
Answer:
D.
All of the
above
 Question 2
0 out of 1 points
An elderly woman with a history of Alzheimer’s disease, coronary artery disease, and
myocardial infarction had a fall at home 3 months ago that resulted in her receiving an
open reduction internal fixation. While assessing this patient, the PMHNP is made aware
that the patient continues to experience mild to moderate pain. What is the PMHNP most
likely to do?
Selected
Answer:
A.
Order an X-ray because it is possible that she
dislocated her hip.
 Question 3
1 out of 1 points
The PMHNP is caring for a patient who reports excessive arousal at nighttime. What could
the PMHNP use for a time-limited duration to shift the patient’s brain from a hyperactive
state to a sleep state?
Selected
Answer:
B.
Benzodiazepi

nes
 Question 4
1 out of 1 points
A patient addicted to heroin is receiving treatment for detoxification. He begins to
experience tachycardia, tremors, and diaphoresis. What medication will the PMHNP
prescribe for this patient?
Selected
Answer:
D.
Clonidine
(Catapres)
 Question 5
1 out of 1 points
The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic pain. How does the
PMHNP anticipate the drug to work?
Selected
Answer:
A.
It will bind to the alpha-2-delta ligand subunit of voltage-sensitive
calcium channels.
 Question 6
1 out of 1 points
A patient with hypersexual disorder is being assessed for possible pharmacologic
treatment. Why does the PMHNP prescribe an antiandrogen for this patient?
Selected
Answer:
C.
It will block
testosterone.
 Question 7
1 out of 1 points
Which statement best describes a pharmacological approach to treating patients for
impulsive aggression?
Selected
Answer:
D.
Opioid antagonists can be used to
reduce drive.

 Question 8
1 out of 1 points
A 26-year-old female patient with nicotine dependence and a history of anxiety presents
with symptoms of attention deficit hyperactivity disorder (ADHD). Based on the
assessment, what does the PMHNP consider?
Selected
Answer:
A.
ADHD is often not the focus of treatment in adults with
comorbid conditions.
 Question 9
1 out of 1 points
A patient with irritable bowel syndrome reports chronic stomach pain. The PMHNP wants
to prescribe the patient an agent that will cause irrelevant nociceptive inputs from the
pain to be ignored and no longer perceived as painful. Which drug will the PMHNP
prescribe?
Selected
Answer:
C.
Duloxetine
(Cymbalta)
 Question 10
1 out of 1 points
Parents of a 12-year-old boy want to consider attention deficit hyperactivity disorder
(ADHD) medication for their son. Which medication would the PMHNP start?
Selected
Answer:
All of the above could potentially treat their
son’s symptoms.
 Question 11
1 out of 1 points
Which of the following is a true statement regarding the use of stimulants to treat
attention deficit hyperactivity disorder (ADHD)?
Selected
Answer:
B.
Signal strength output is increased by dialing up the release of
dopamine (DA) and norepinephrine (NE).
 Question 12
1 out of 1 points
Mr. Peterson is meeting with the PMHNP to discuss healthier dietary habits. With a BMI of

33, Mr. Peterson is obese and needs to modify his food intake. “Sometimes I think I’m
addicted to food the way some people are addicted to drugs,” he says. Which statement
best describes the neurobiological parallels between food and drug addiction?
Selected
Answer:
A.
There is decreased activation of the
prefrontal cortex.
 Question 13
1 out of 1 points
A 72-year-old male patient is in the early stages of Alzheimer’s disease. The PMHNP
determines that improving memory is a key consideration in selecting a medication.
Which of the following would be an appropriate choice?
Selected
Answer:
D.
All of the
above
 Question 14
1 out of 1 points
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What
should the PMHNP include when discussing the side effects with the patient?
Selected
Answer:
C.
The medication can affect your blood
pressure.
 Question 15
1 out of 1 points
The parents of a 7-year-old patient with ADHD are concerned about the effects of
stimulants on their child. The parents prefer to start pharmacological treatment with a
non-stimulant. Which medication will the PMHNP will most likely prescribe?
Selected
Answer:
A.
Stratt
era
 Question 16
1 out of 1 points
The PMHNP is assessing a patient who has expressed suicidal intent and is now stating
that he is hearing voices and sees people chasing him. The PMHNP identifies these
symptoms to be associated with which of the following?

Selected
Answer:
C.
“Bath salt”
intoxication
 Question 17
1 out of 1 points
An 80-year-old female patient diagnosed with Stage II Alzheimer’s has a history of
irritable bowel syndrome. Which cholinergic drug may be the best choice for treatment
given the patient’s gastrointestinal problems?
Selected
Answer:
A.
Donepezil
(Aricept)
 Question 18
1 out of 1 points
A 63-year-old patient presents with the following symptoms. The PMHNP determines
which set of symptoms warrant prescribing a medication? Select the answer that is
matched with an appropriate treatment.
Selected
Answer:
B.
Impairment in the ability to learn and retain new information is most
problematic, and an appropriate treatment option would be donepezil.
 Question 19
1 out of 1 points
The PMHNP is caring for a patient with chronic insomnia who is worried about
pharmacological treatment because the patient does not want to experience
dependence. Which pharmacological treatment approach will the PMHNP likely select for
this patient for a limited duration, while searching and correcting the underlying
pathology associated with the insomnia?
Selected
Answer:
D.
Non-benzodiazepine
hypnotics
 Question 20
1 out of 1 points
The PMHNP is performing a quality assurance peer review of the chart of another PMHNP.
Upon review, the PMHNP reviews the chart of an older adult patient in long-term care
facility who has chronic insomnia. The chart indicates that the patient has been receiving
hypnotics on a nightly basis. What does the PMHNP find problematic about this
documentation?

Loading page 6...

5 more pages available. Scroll down to load them.

Preview Mode

100%

Study Now!

XY-Copilot AI

Unlimited Access

Secure Payment

Instant Access

24/7 Support

Document Chat

Document Details

University

Walden University

Subject

Nursing

2019 NURS-6630N Nursing Diagnosis Week 11 Final Exam With Answers (76 Solved Questions)

Study Now!

Document Details

Related Documents

NURS6630N Pharmacology Final Exam Week 11 With Answers (76 Solved Questions)

The Evolution of Nursing Science: Key Theories and Their Impact on Patient Care

Pediatric Gastrointestinal Disorders: Pathophysiology, Clinical Manifestations, Treatments, and Nursing Management

NUR/443 Cost and Effects of Performance Feedback and Nurse Case Management

NRS-427V Week 2 Epidemiology Paper

NRS-427V Week 2 Epidemiology and Communicable Diseases Paper

NR660 Capstone Chamberlain College of Nursing Evaluation of epidemiology Problem

NUR440 Case Study 5 Acute Renal Failure

Chamberlain College of Nursing NR503 Population Health, Epidemiology, & Statistical Principles

Nursing Entrance Exams Test Easy (2019)

Company

Explore

Study Tools